Drug Shortage Report for NUCYNTA EXTENDED-RELEASE
Report ID | 101052 |
Drug Identification Number | 02415615 |
Brand name | NUCYNTA EXTENDED-RELEASE |
Common or Proper name | TAPENTADOL |
Company Name | ENDO OPERATIONS LTD. |
Market Status | MARKETED |
Active Ingredient(s) | TAPENTADOL |
Strength(s) | 250MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60 Tabs |
ATC code | N02AX |
ATC description | OPIOIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-12-11 |
Actual start date | |
Estimated end date | 2019-12-31 |
Actual end date | 2019-12-18 |
Shortage status | Resolved |
Updated date | 2019-12-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-12-11 | English | Compare |
v2 | 2019-12-11 | French | Compare |
v3 | 2019-12-12 | English | Compare |
v4 | 2019-12-19 | English | Compare |
v5 | 2019-12-19 | French | Compare |
Showing 1 to 5 of 5